Tag: Health and Medical
-
Pristine Rejuvenation Expands to Accommodate Growth
WEST BLOOMFIELD, Mich. — A bigger office suite means better patient care for Pristine Rejuvenation, a med spa that focuses on aesthetic injectables and skin rejuvenation treatments. Eman Dahmani, company Principal, announced that the new facilities were opened to handle the spa’s steady growth.
-
National Nurses Week Kicks Off with Virtual Portrait Exhibition Honoring Pandemic Healthcare Workers
LOS ANGELES, Calif. — Producer and photographer Mariana Tosca of Blue Jasper Productions and Tosca Photography announces the launch of “Covid Courageous.” This unique virtual exhibition blends photographic portraiture with interviews of frontline healthcare workers, which spotlight each individual’s personal pandemic experience.
-
Zeteo Biomedical Introduces OrionMRQ™ Nasal Delivery Device for Vaccines
PFLUGERVILLE, Texas — Zeteo Biomedical LLC announced today the availability of the ZEOx1 OrionMRQ™ nasal drug and vaccine delivery device. Zeteo’s latest innovative delivery device provides pharmaceutical and biotech companies developing drugs, peptides, proteins, monoclonal antibodies and vaccines with precise, metered unit dose systemic delivery via the nasal route.
-
Kalyagen Announces Attendance at the Fort Lauderdale Open with PGA Associate Jerrel Gill
AUSTIN, Texas — Kalyagen® is pleased to announce that it will be attending the Fort Lauderdale Open as part of its sponsorship of golf professional Jerrel Gill. The Open will be hosted at the Fort Lauderdale Country Club on May 2-3, 2022.
-
Kalyagen Announces Attendance at Paleo f(x) 2022 Conference
AUSTIN, Texas — Kalyagen is pleased to announce that it will be attending and hosting a booth (#121) at the upcoming Paleo f(x)™ 2022 conference to be held in Austin on April 29 – May 1. STEMREGEN® is a unique and patent-pending blend of proprietary plant-based extracts documented to increase the number of circulating stem…
-
Atlanta Facial Plastic Surgeon Dr. Elizabeth Whitaker recognized with several local and national distinctions
ATLANTA, Ga. — Elizabeth Whitaker, M.D., F.A.C.S., owner and founder of Atlanta Face & Body, has been recognized by several renowned national and local publications for her outstanding work in plastic surgery and minimally invasive aesthetic treatments. The most recent of these was being named in Modern Luxury’s “Top Doctor Spotlight.”
-
Edgewood Healthcare Advisors Continues Growth with Strategic Hires
NEW YORK, N.Y. — Edgewood Healthcare Advisors, a division of EPIC Insurance Brokers and Consultants, a retail property and casualty insurance brokerage and employee benefits consultant, announced today that it has hired a team of healthcare experts to help continue to expand its healthcare practice expertise in the Southeast Region.
-
Oral Vaccine Boosts COVID Immunity: study conducted on nonhuman primates is published in the journal Vaccine
ROCHESTER, Minn. — Vyriad, Inc., a clinical-stage biotechnology company developing oncolytic virus therapies to treat a wide range of cancers, today announced results confirming the activity of an oral vaccine formulation for boosting immunity against SARS-CoV-2. The full study conducted on nonhuman primates is published in the journal Vaccine.
-
Myrio Therapeutics and Pure MHC, LLC Announce Research Collaboration to Develop Novel, Targeted Antibody-Based Cancer Therapies
OKLAHOMA CITY, Okla. — Pure MHC, LLC and Myrio Therapeutics Pty Ltd (Myrio) today announced a collaboration to develop new antibody-based oncology therapeutics. The companies will combine Pure MHC’s proprietary offering of MHC peptide targets for oncology with Myrio’s revolutionary Retained Display(tm) (ReD) antibody discovery process to initially create up to three novel therapies based…
-
Neurosoft Bioelectronics Receives Nearly $3 Million in Funding
NEW YORK, N.Y. — Neurosoft Bioelectronics, an early-stage company developing tools for unmet needs in epilepsy and tinnitus, was awarded nearly $3 million USD, from the SERI-Funded European Innovation Council Accelerator Grant and a share of the $165,000 USD through the European Research Council Proof-of-Concept Grant.